![]() Soligenix Soligenix develops biodefense vaccines and therapeutics for the side-effects of cancer treatment and gastrointestinal diseases. | Angiochem Angiochem is a biotech company discovering and developing medications that are crossing the blood-brain barrier (BBB) to treat brain diseases. | ![]() OxThera OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate. | |
Founding Date | Founding Date 1987 | Founding Date 2003 | Founding Date N/A |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Princeton, US HQ | Locations Westmount, CA HQ | Locations Stockholm, SE HQ Knoxville, US |
Employees | Employees 1422% decrease | Employees 10 | Employees 7 |
Financial | |||
Net income | Net income ($11.1m) (FY, 2025) | Net income N/A | Net income (kr37.8m) (FY, 2015) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 17.3m | Total funding raised $ 53.3m |
Angiochem is a biotech company discovering and developing medications that are crossing the blood-brain barrier (BBB) to treat brain diseases.
View company
OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.
View company